Skip to content
lsd.com

Indication

Mood Disorders

5 registered trials testing Psilocybin, Ketamine for this indication, 1 recruiting now.

5
Registered trials
1
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Mood Disorders trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 5 trials for Mood Disorders

TrialStatusPhaseSubstanceSites
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionNCT06511908 · National Institute of Mental Health (NIMH)RecruitingPhase 2ketamine1
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of PsilocybinNCT06341426 · University Health Network, TorontoActive, not recruitingPhase 2psilocybin2
Rapid Antidepressant Effects of Ketamine in Major DepressionNCT00088699 · National Institute of Mental Health (NIMH)CompletedPhase 1 / Phase 2ketamine1
Esketamine vs ECT for Acute SuicidalityNCT06355180 · Capital Medical UniversityCompletedNot applicableketamine6
Synaptic Imaging and Network Activity in Treatment Resistant DepressionNCT05870501 · King's College LondonCompletedNot applicableketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.